|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.50 SEK | -2.30% |
|
+5.11% | +2.65% |
| 12/06 | Handelsbanken Fonder increases stake in Alligo to just over 5 percent | FW |
| 08/06 | Espiria Sweden Small Cap rose 6.1 percent in May - Hansa Biopharma contributed positively | FW |
Company Valuation: Alligo AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 9,692 | 4,003 | 6,206 | 6,168 | 6,421 | 6,742 | - | - |
| Change | - | -58.7% | 55.04% | -0.61% | 4.1% | 4.99% | - | - |
| Enterprise Value (EV) 1 | 11,964 | 4,003 | 8,846 | 9,071 | 9,564 | 9,427 | 9,060 | 8,678 |
| Change | - | -66.54% | 120.98% | 2.54% | 5.43% | -1.43% | -3.9% | -4.21% |
| P/E | 22.6x | 0.99x | 12.7x | 22.5x | 24.6x | 14.3x | 11.4x | 9.94x |
| PBR | 2.83x | - | 1.75x | 1.69x | 1.71x | 1.62x | 1.48x | 1.34x |
| PEG | - | 0x | -0.1x | -0.5x | -5.18x | 0.2x | 0.5x | 0.7x |
| Capitalization / Revenue | 1.14x | 0.43x | 0.66x | 0.65x | 0.67x | 0.66x | 0.63x | 0.6x |
| EV / Revenue | 1.41x | 0.43x | 0.93x | 0.96x | 0.99x | 0.93x | 0.84x | 0.77x |
| EV / EBITDA | 9.9x | 3.47x | 6.91x | 7.92x | 8.81x | 6.99x | 5.94x | 5.25x |
| EV / EBIT | 28x | 5.98x | 11.8x | 18x | 20.3x | 13.3x | 10.6x | 9x |
| EV / FCF | 15.5x | - | 11.4x | 10.8x | 13.8x | 9.07x | 8.68x | 7.79x |
| FCF Yield | 6.45% | - | 8.79% | 9.27% | 7.27% | 11% | 11.5% | 12.8% |
| Dividend per Share 2 | 1.75 | - | 3.5 | 2 | 2.2 | 3.62 | 4.332 | 5.068 |
| Rate of return | 0.91% | - | 2.82% | 1.62% | 1.72% | 2.69% | 3.22% | 3.76% |
| EPS 2 | 8.48 | 80.44 | 9.76 | 5.47 | 5.21 | 9.39 | 11.76 | 13.54 |
| Distribution rate | 20.6% | - | 35.9% | 36.6% | 42.2% | 38.6% | 36.8% | 37.4% |
| Net sales 1 | 8,508 | 9,333 | 9,462 | 9,442 | 9,638 | 10,166 | 10,747 | 11,265 |
| EBITDA 1 | 1,208 | 1,155 | 1,281 | 1,146 | 1,085 | 1,348 | 1,524 | 1,653 |
| EBIT 1 | 427 | 669 | 748 | 505 | 471 | 707.5 | 853.2 | 964.2 |
| Net income 1 | 429 | 4,061 | 497 | 274 | 261 | 472.5 | 588.8 | 678.8 |
| Net Debt 1 | 2,272 | - | 2,640 | 2,903 | 3,143 | 2,686 | 2,318 | 1,936 |
| Reference price 2 | 192.00 | 79.30 | 124.00 | 123.20 | 128.20 | 134.60 | 134.60 | 134.60 |
| Nbr of stocks (in thousands) | 50,481 | 50,481 | 50,051 | 50,068 | 50,088 | 50,088 | - | - |
| Announcement Date | 15/02/22 | 16/02/23 | 16/02/24 | 14/02/25 | 13/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.33x | 0.93x | 6.99x | 2.69% | 70Cr | ||
| 29.48x | 3.34x | 19.4x | 0.72% | 6.34TCr | ||
| 39.28x | 6.1x | 26.9x | 1.91% | 5.58TCr | ||
| 35.17x | 5.55x | 20.64x | 0.91% | 1.29TCr | ||
| 30.9x | 2.46x | 19.98x | 0.58% | 1.22TCr | ||
| 16.52x | 1.3x | 10.49x | -.--% | 841.06Cr | ||
| 27.44x | 1.8x | 15.31x | 2.85% | 685.68Cr | ||
| 16.04x | 1.06x | 9.29x | 3.93% | 379.12Cr | ||
| 25.32x | - | - | - | 244.95Cr | ||
| 31.35x | 3.19x | 18.33x | 1.12% | 254.59Cr | ||
| Average | 26.58x | 2.86x | 16.37x | 1.63% | 1.69TCr | |
| Weighted average by Cap. | 32.13x | 4.14x | 21.13x | 1.26% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ALLIGO B Stock
- Valuation Alligo AB
Select your edition
All financial news and data tailored to specific country editions
















